Queen's Award for Valid Insight
Pharmaceutical global market access consultancy Valid Insight has been named as one of a select number of businesses to win the Queen’s Award for Enterprise: International Trade. The Queen’s Awards for Enterprise are the UK’s most esteemed business awards. Valid Insight, which provides expert consultancy services that guide clients in the pharmaceutical, biotech and medical device industry to global market access success, is to be honoured in recognition of its growth strategy. Since being established in 2016, the company has grown exponentially, with their international client base and sales expanding by almost 800% in the last three years. Valid Insight’s founder and Managing Director, Steve Bradshaw, who will attend a Royal Reception at Buckingham Palace in June hosted by HRH The Prince of Wales, commented: “We are honoured to receive the Queen’s Award for Enterprise in International Trade. We compete against a strong set of consultancy firms on a global level and to win this award means that what we are doing is world class”. Bradshaw added that the Queen’s Award “strengthens our reputation as a leader” and “will further encourage us to extend our high standard of expertise in the challenging area of pharmaceutical market access, helping more multinational companies bring better medicines to patients across the world”.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.
